PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Mental Health Anxiety

Why stopping SSRIs can cause anxiety: A rebound in serotonin neuron activity may play a role

by Vladimir Hedrih
November 19, 2026
Reading Time: 3 mins read
Add as a preferred source on GoogleFollow on Google News

A study of male mice found that stopping treatment with the SSRI antidepressant paroxetine was associated with increased activity in two brain areas involved in anxiety, the dorsal raphe nucleus and the ventral hippocampus. These changes appeared two days after treatment ended, when the mice also showed elevated anxiety-like behavior. Five days after discontinuation, the anxiety-like behavior had subsided, but activation of serotonin-producing neurons in the dorsal raphe nucleus persisted. The paper was published in Neuropharmacology.

Selective serotonin reuptake inhibitors, or SSRIs, are a widely used class of antidepressant medications. They are commonly prescribed to treat depression and some anxiety disorders. SSRIs work by blocking the reabsorption of serotonin, a neurotransmitter involved in regulating mood and other psychological processes, thereby increasing its availability in the brain.

However, abruptly stopping SSRI treatment can cause withdrawal-like symptoms, including increased anxiety, sleep disturbances, and unusual sensory experiences. These symptoms typically appear within a few days of discontinuation and can persist for several weeks or even longer. Animal studies have shown that stopping SSRI treatment can also produce behavioral changes resembling anxiety, including increased vigilance and avoidance of potentially threatening environments.

Previous research by the same team found that anxiety-like behavior in mice appeared two days after paroxetine was discontinued but had disappeared by five days, although disturbances in sleep and reduced weight gain lasted longer. Scientists believe that these effects may involve changes in the activity of brain circuits regulating anxiety, particularly those involving serotonin-producing neurons.

Free daily newsletter

Don’t miss the next big psychology finding

Every morning, PsyPost sends a short briefing on the most interesting new peer-reviewed research in psychology and neuroscience.

✓ Free ✓ One email a day ✓ Unsubscribe anytime

Study author Helen M. Collins of the University of Oxford and colleagues investigated how discontinuing paroxetine affects c-Fos immunoreactivity in a range of brain regions linked to anxiety. The protein c-Fos helps regulate gene expression and is produced in increased amounts in neurons after they become active, which makes it useful as a marker of recent neuronal activity. Researchers can detect this protein using antibodies, a technique known as c-Fos immunoreactivity, to identify neurons that have recently been activated.

The study was conducted on male mice that were seven weeks old at the start of the study. The mice were housed in groups of three littermates. The researchers studied only males because their previous research did not find evidence that discontinuing paroxetine increases anxiety in female mice.

Mice were randomly assigned to one of three groups of 12. For 12 days, two groups received daily injections of paroxetine (10 mg/kg) and one group received saline injections. Afterward, the saline group and one paroxetine group continued their treatments for another two or five days, while the third group, the discontinuation group, was switched from paroxetine to saline injections.

All mice were then tested on an elevated plus maze, a standard test of anxiety-like behavior in rodents. Ninety minutes later, six or seven randomly selected mice from each group were euthanized, and their brains were examined for signs of recent neuronal activity using c-Fos immunoreactivity. The behavioral results from these mice were reported in the team’s earlier paper.

Two days after paroxetine discontinuation, when the mice showed elevated anxiety-like behavior, neural activity was increased in the dorsal raphe nucleus and the ventral hippocampus compared with mice receiving saline. No such increases were found in other anxiety-related regions the researchers examined, including the median raphe nucleus, prefrontal cortex, amygdala, periaqueductal grey, and paraventricular nucleus of the hypothalamus.

In the dorsal raphe nucleus, the main source of serotonin for the forebrain, the increased activity occurred in serotonin-producing neurons, including a subgroup of neurons that produce both serotonin and glutamate. The authors suggest that stopping an SSRI may suddenly release serotonin neurons from the inhibition they experience during ongoing treatment, producing a rebound in their activity.

Five days after discontinuation, serotonin neurons in the dorsal raphe nucleus were still more active, but the mice no longer showed increased anxiety-like behavior. Activity in the ventral hippocampus and in the serotonin-glutamate neurons had also returned to normal by this point. The authors note that activation of serotonin neurons alone may therefore not be sufficient to produce anxiety, while ventral hippocampus activity followed the same time course as the anxiety-like behavior.

“These findings suggest that, under the current conditions, paroxetine discontinuation is associated with a short-lasting activation of anxiety-promoting circuitry limited to DRN 5-HT neurons [dorsal raphe nucleus neurons that produce serotonin] and the hippocampus. This circuitry may contribute to symptoms such as anxiety that are a feature of SSRI discontinuation syndrome,” the study authors concluded.

The study contributes to the scientific understanding of brain changes following SSRI discontinuation. However, it should be noted that the study was conducted on mice, not humans, and effects in humans might differ. The study also included only male mice, and the brain analyses involved six or seven mice per group, which may have limited the ability to detect subtle changes in other brain regions. In addition, c-Fos provides only a snapshot of recent neural activity, and the study cannot establish that the observed brain changes caused the anxiety-like behavior.

The paper, “Increased c-Fos immunoreactivity in anxiety-related brain regions following paroxetine discontinuation,” was authored by Helen M. Collins, L. Sophie Gullino, Cara Fuller, Raquel Pinacho, David M. Bannerman, and Trevor Sharp.

TweetSendScanShareSendPinShareShareShareShareShare

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • New research finds high testosterone does not impair men’s emotional reframing
  • Psychedelics trigger a bizarre memory paradox that makes the unknown feel like home
  • Musically trained children score higher on tests of intelligence, working memory, and reading
  • Republicans experience worse mental health in Democratic neighborhoods, study finds
  • New study finds children and teens reason differently about participation trophies

Science of Money

  • What psychology reveals about how founders dial startup obsession up or down
  • New study reveals what actually predicts livestream shopping sales
  • How eating a product today shapes which brand you buy tomorrow
  • The psychology of buying clothes you haven’t seen
  • The hidden social cost of cashierless stores

Recent

  • GLP-1 drugs linked to reduced alcohol use and healthier eating in real-world study
  • Heavy cannabis use linked to mild psychotic symptoms and depressive thoughts
  • Does personality predict family size? A 15,000-person study across three countries weighs in
  • A 30-minute walk helps sustain brain activity during mental task switching, study finds
  • Scientists finally pin down what a mysterious Alzheimer’s gene does
  • Childhood trauma and ADHD independently fuel risky driving habits, study suggests
  • New psychology study suggests your sexual turn-ons are far more fluid than assumed
  • Past experiences with classical music predict a taste for sophisticated genres
  • The genetic influences on drinking may shift between adolescence and early adulthood
  • Brain damage linked to “pseudopsychopathy” may not reduce the will to empathize

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • FAQ
  • Jobs

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc